Implementation of this test is limited to AKI risk assessment in post-operative cardiac surgery patients. The Astute Medical NEPHROCHECK® Test System is intended to be used in conjunction with clinical evaluation in ICU patients who currently have, or have had within the past 24 hours, acute cardiovascular and/or respiratory compromise as an aid in the risk assessment for moderate to severe AKI in the next 12 hours of patient assessment. The NEPHROCHECK® Test System is intended to be used in patients 21 years of age or older.
No specified reference range for this test. The following interpretation will accompany each result as a result level comment:
Nephrocheck AKI Risk Score Interpretation:
Risk Score <0.3 – low risk of developing moderate to severe AKI.
Risk Score 0.3 to 2.0 – moderate risk of developing moderate to severe AKI.
Risk Score >2.0 – high risk of developing moderate to severe AKI.
albumin above 3000 mg/dl cause an invalid test result. Use caution interpreting results with
B. Urine Bilirubin concentrations above 7.2 mg/dl interfere with the Nephrocheck results. Use caution interpreting results with severe hyperbilirubinemia.
C. Methylene blue at concentrations of 0.49 mg/L interferes with Nephrocheck results
Urine samples collected with additives or preservatives will be rejected.